Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 23;13:919145. doi: 10.3389/fimmu.2022.919145

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhang, Xie, Huang, Zhong, Liu, Cheong, Zhou and Tang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Immune cell infiltration landscape of PRRT3-AS1 in TCGA-SKCM. (A) Level of immune cell infiltration comparing PRRT3-AS1 high group and PRRT3-AS1 low group. (B) Level of immune checkpoint comparing PRRT3-AS1 high group and PRRT3-AS1 low group. (C) The distribution of B cell, CD4+ T cell, CD8+ T cell, neutrophil, macrophage, myeloid dendritic cell count, and the expression level of PRRT3-AS1. (D) The co-expression of interferon-gamma (IFNG) and PRRT3-AS1. (E) The co-expression of immune exclusion score and PRRT3-AS1. (F) PRRT3-AS1 expression in the immunotherapy response group and immunotherapy non-response group. ^* P < 0.05, ^** P < 0.01, ^*** P < 0.001.